Nymox Pharmaceutical
NYMX
#10114
Rank
S$23.27 M
Marketcap
Country
S$0.26
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -S$3.04 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -S$8.33 Million, an increase over its 2021 earnings that were of -S$15.92 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -S$3.04 Million-63.53%
2022 -S$8.33 Million-47.71%
2021 -S$15.92 Million6.61%
2020 -S$14.94 Million-10.91%
2019 -S$16.76 Million24.24%
2018 -S$13.49 Million-20.03%
2017 -S$16.87 Million2.71%
2016 -S$16.43 Million-63.86%
2015 -S$45.45 Million674.44%
2014 -S$5.87 Million-6.11%
2013 -S$6.25 Million-35.66%
2012 -S$9.72 Million-20.76%
2011 -S$12.26 Million38.33%
2010 -S$8.87 Million35.59%
2009 -S$6.54 Million11.8%
2008 -S$5.85 Million-12.94%
2007 -S$6.72 Million8.85%
2006 -S$6.17 Million36.5%
2005 -S$4.52 Million-4.4%
2004 -S$4.73 Million-14.58%
2003 -S$5.54 Million
2001 -S$4.07 Million-20.54%
2000 -S$5.11 Million21.72%
1999 -S$4.2 Million-25.56%
1998 -S$5.64 Million101.3%
1997 -S$2.81 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$41.31 B-1,499,220.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$15.11 B-548,549.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$10.37 B-376,684.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$28.70 B-1,041,451.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
S$1.64 B-59,655.76%๐Ÿ‡บ๐Ÿ‡ธ USA